Works about PANCREATIC cancer treatment
Results: 1408
Selective Cytotoxicity of Ponciri Fructus against Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells via Blocking Activation of GRP78.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2009, v. 73, n. 10, p. 2167, doi. 10.1271/bbb.90235
- By:
- Publication type:
- Article
Multiple Layer-by-Layer Lipid-Polymer Hybrid Nanoparticles for Improved FOLFIRINOX Chemotherapy in Pancreatic Tumor Models.
- Published in:
- Advanced Functional Materials, 2015, v. 25, n. 5, p. 788, doi. 10.1002/adfm.201401583
- By:
- Publication type:
- Article
Preoperative chemoradiotherapy does not compromise the feasibility of adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma.
- Published in:
- Surgery Today, 2017, v. 47, n. 2, p. 218, doi. 10.1007/s00595-016-1405-6
- By:
- Publication type:
- Article
Concurrent gemcitabine+S-1 neoadjuvant chemotherapy contributes to the improved survival of patients with small borderline-resectable pancreatic cancer tumors.
- Published in:
- Surgery Today, 2016, v. 46, n. 11, p. 1282, doi. 10.1007/s00595-016-1310-z
- By:
- Publication type:
- Article
Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review.
- Published in:
- Surgery Today, 2016, v. 46, n. 9, p. 1045, doi. 10.1007/s00595-015-1292-2
- By:
- Publication type:
- Article
Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells.
- Published in:
- Biotechnology & Applied Biochemistry, 2017, v. 64, n. 2, p. 165, doi. 10.1002/bab.1446
- By:
- Publication type:
- Article
Prognostic Factors in Advanced Pancreatic Cancer: Single-Center, Real-World Data.
- Published in:
- Eurasian Journal of Medical Investigation, 2022, v. 6, n. 2, p. 203, doi. 10.14744/ejmi.2022.38962
- By:
- Publication type:
- Article
Leser-Trélat Sign as a Marker for Underlying Pancreatic Cancer.
- Published in:
- Clinical Practice & Cases in Emergency Medicine, 2023, v. 7, n. 3, p. 202, doi. 10.5811/cpcem.1248
- By:
- Publication type:
- Article
Gastric Venous Congestion Following Total Pancreatectomy With Splenectomy. Should We Care? How To Prevent? A Report Of A Rare Case.
- Published in:
- Surgical Chronicles, 2023, v. 28, n. 4, p. 458
- By:
- Publication type:
- Article
Predicting a Response to FOLFIRINOX in Pancreatic Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 2, p. 1, doi. 10.1093/jnci/dju413
- By:
- Publication type:
- Article
Therapeutic Advances in Pancreatic Cancer: Miles to Go Before We Sleep.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
MAX-ing Out MYC: A Novel Small Molecule Inhibitor Against MYC-Dependent Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 12, p. 1, doi. 10.1093/jnci/dju365
- By:
- Publication type:
- Article
Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 3, p. 1, doi. 10.1093/jnci/dju011
- By:
- Publication type:
- Article
Pancreatic Cancer: Will Incremental Advances Begin To Make a Difference?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 24, p. 1821, doi. 10.1093/jnci/djq521
- By:
- Publication type:
- Article
Pancreatic Cancer Research Matures.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 19, p. 1432, doi. 10.1093/jnci/djm180
- By:
- Publication type:
- Article
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response.
- Published in:
- Cell Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41421-021-00271-4
- By:
- Publication type:
- Article
Fixed-Dose-Rate Gemcitabine: A Viable First-Line Treatment Option for Advanced Pancreatic and Biliary Tract Cancer.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 1E, doi. 10.1634/theoncologist.2008-0135
- By:
- Publication type:
- Article
S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Cystic gastric metastasis from pancreatic cancer.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A long-term survival case treated with conversion surgery following chemotherapy after diagnostic metastasectomy for pancreatic cancer with synchronous liver metastasis.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0409-9
- By:
- Publication type:
- Article
Synchronous primary gallbladder and pancreatic cancer associated with congenital biliary dilatation and pancreaticobiliary maljunction.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0388-x
- By:
- Publication type:
- Article
Metastatic mixed acinar-endocrine carcinoma of the pancreas treated with a multidisciplinary approach: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0326-y
- By:
- Publication type:
- Article
Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0290-6
- By:
- Publication type:
- Article
Radical resection of T1 pancreatic adenocarcinoma with a pseudocyst of the tail due to acute obstructive pancreatitis: report of a case.
- Published in:
- Surgical Case Reports, 2016, v. 2, n. 1, p. 1, doi. 10.1186/s40792-016-0268-9
- By:
- Publication type:
- Article
MODERATELY DIFFERENTIATED DUCTAL CARCINOMA PANCREAS INVOLVING PERIAMPULLARY REGION.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Management of Benign and Malignant Pancreatic Duct Strictures.
- Published in:
- Clinical Endoscopy, 2018, v. 51, n. 2, p. 156, doi. 10.5946/ce.2017.085
- By:
- Publication type:
- Article
Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00857
- By:
- Publication type:
- Article
Characterization of Pancreatic Cancer Tissue Using Multiphoton Excitation Fluorescence and Polarization-Sensitive Harmonic Generation Microscopy.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00272
- By:
- Publication type:
- Article
Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00246
- By:
- Publication type:
- Article
Porcine Models of Pancreatic Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00144
- By:
- Publication type:
- Article
Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00056
- By:
- Publication type:
- Article
Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00046
- By:
- Publication type:
- Article
Pro-tumour activity of interleukin-22 in HPAFII human pancreatic cancer cells.
- Published in:
- Clinical & Experimental Immunology, 2012, v. 168, n. 2, p. 192, doi. 10.1111/j.1365-2249.2012.04570.x
- By:
- Publication type:
- Article
Review article: current treatment and optimal patient management in pancreatic cancer.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1998, v. 12, n. 10, p. 949, doi. 10.1046/j.1365-2036.1998.00390.x
- By:
- Publication type:
- Article
NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer.
- Published in:
- Oncogene, 2015, v. 34, n. 37, p. 4879, doi. 10.1038/onc.2014.409
- By:
- Publication type:
- Article
MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
- Published in:
- Oncogene, 2015, v. 34, n. 37, p. 4867, doi. 10.1038/onc.2014.408
- By:
- Publication type:
- Article
Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
- Published in:
- Oncogene, 2015, v. 34, n. 34, p. 4439, doi. 10.1038/onc.2014.379
- By:
- Publication type:
- Article
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
TXNDC12 inhibits pancreatic tumor cells ferroptosis by regulating GSH/GGT7 and promotes its growth and metastasis.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 12, p. 3913, doi. 10.7150/jca.93208
- By:
- Publication type:
- Article
Prognostic significance of BRCA1 and BRCA2 methylation status in circulating cell-free DNA of Pancreatic Cancer patients.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 9, p. 2573, doi. 10.7150/jca.93184
- By:
- Publication type:
- Article
Enhancement of Tumorigenicity, Spheroid Niche, and Drug Resistance of Pancreatic Cancer Cells in Three-Dimensional Culture System.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 8, p. 2292, doi. 10.7150/jca.87494
- By:
- Publication type:
- Article
Contribution of a Circulating 2'-O-methylated MicroRNA Panel to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 6, p. 1583, doi. 10.7150/jca.91716
- By:
- Publication type:
- Article
Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 2, p. 401, doi. 10.7150/jca.89665
- By:
- Publication type:
- Article
Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 1, p. 251, doi. 10.7150/jca.88397
- By:
- Publication type:
- Article
Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 14, p. 2694, doi. 10.7150/jca.87596
- By:
- Publication type:
- Article
The NT5DC family: expression profile and prognostic value in pancreatic adenocarcinoma.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 12, p. 2274, doi. 10.7150/jca.85811
- By:
- Publication type:
- Article
Tripartite motif containing 69 elicits ERK2-dependent EYA4 turnover to impart pancreatic tumorigenesis.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 2, p. 200, doi. 10.7150/jca.79905
- By:
- Publication type:
- Article
Pancreatic cancer -- challenge for modern medicine.
- Published in:
- Polish Journal of Public Health, 2024, v. 134, p. 89, doi. 10.12923/2083-4829/2024-0019
- By:
- Publication type:
- Article
Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2017, v. 40, n. 2, p. 167, doi. 10.1007/s13402-017-0314-z
- By:
- Publication type:
- Article